Previous Research Funded
The Pulmonary Fibrosis Foundation remains deeply committed to working with researchers to develop new treatments for IPF. Since the Foundation was established in 2000, we have funded or are committed to fund nearly $2.9 million towards our ambitious goal of finding a cure for this disease. Our funding has been focused on basic science, translational research, genetics, and even stem cell studies in an effort to learn more about the cause and progression of pulmonary fibrosis.
The Pulmonary Fibrosis Foundation (PFF) announced October 17, 2011, that it has established the PFF Research Fund to Cure Pulmonary Fibrosis, a fund created to support research that will assist in the development of successful therapies for pulmonary fibrosis (PF). View the Policies and Guidelines.
Multi-Year Partnerships
University of Chicago ($1,000,000): Multiyear funding to establish the Pulmonary Fibrosis Foundation Research Center of Excellence at the University of Chicago. The research will cover two areas. First, to find an effective treatment for Pulmonary Fibrosis. Second, to study the high rejection and failure rate in Lung Transplants and find a solution to this problem. This gift has been provided since 2006, and is expected to be fully funded by 2010.
2011 Funded Research
$50,000 - Erica Herzog, MD, Assistant Professor of Medicine in the Pulmonary and Critical Care Division at Yale University (New Haven, CT), was awarded a Partner Grant to investigate emaphorin 7a and alternative macrophage activation in idiopathic pulmonary fibrosis. PFF funded $50,000 of the total $100,000, two-year grant through the 2011 CPF/PFF/ATS Partner Grant Program.
$50,000 - Steven Huang, MD, Lecturer in the Department of Medicine at the University of Michigan (Ann Arbor, MI), was awarded a Partner Grant to investigate the regulation and pattern of the DNA methylome in pulmonary fibrosis. PFF funded $50,000 of the total $100,000, two-year grant through the 2011 CPF/PFF/ATS Partner Grant Program.
$50,000 - Philip Simonian, MD, Assistant Professor in the Department of Pulmonary Sciences and Critical Care Medicine at the University of Colorado Denver, was awarded a Partner Grant to investigate whether IL-22 offers protection from inflammation-induced pulmonary fibrosis. PFF funded $50,000 of the total $100,000, two-year grant through the 2011 CPF/PFF/ATS Partner Grant Program.
$50,000 - Beiyun Zhou, MD, Assistant Professor of Medicine in the Pulmonary and Critical Care Division at the University of Southern California (Los Angeles, CA), was awarded a Partner Grant to investigate whether endoplasmic reticulum (ER) stress induces epithelial-mesenchymal transition (EMT) in alveolar epithelial cells (AEC), and their role in pulmonary fibrosis. PFF funded $50,000 of the total $100,000, two-year grant through the 2011 CPF/PFF/ATS Partner Grant Program.
2010 Funded Research
ATS $100,000
Columbia University Medical Center - IPF/Lung Transplant Research Fund $5,000
$20,000 to University of Maryland - "Open Label Use of Inhaled Cyclosporine in Lung Transplant Recipients" - Dr. A. Iacono
(First payment of a 2-year contract)
$25,000 to University of Chicago - Center of Excellence - Ancillary Research - Dr. Imre Noth
(First payment of a 2-year contract)
2009 Funded Research
University of Chicago ($257,004): Fourth year award in support of the Pulmonary Fibrosis Foundation Research Center of Excellence noted above.
University of Iowa ($73,000): Research awarded: Targeting Vascular Reactivity in IPF.
Loyola University Medical Center, Chicago, Illinois ($50,000): Second year award to Robert Love, MD of the Stritch School of Medicine to further the understanding the specific T and B cell response to collagen type V in Bronchioltis Obliterans Syndrome (BOS) after lung transplantation. First year award of a two year, $100,000 grant.
Massachusetts General Hospital, Boston, Mass ($45,000):Research award to Andrew M. Tager, MD for his program "Targeting the LPA Pathway as a Novel Therapeutic Strategy for IPF."
National Jewish Health, Denver, Colorado ($25,000): To support the NJH genetic counseling program assisting patients and families with IPF.
University of Vermont, Burlington, VT ($20,000): To support an International Conference on Stem Cell Research to be hosted by 2010.
2008 Funded Research
University of Chicago ($689,732): Third year award in support of the Pulmonary Fibrosis Foundation Research Center of Excellence noted above.
Loyola University Medical Center, Chicago, Illinois ($50,000): First year award to Robert Love, MD of the Stritch School of Medicine to further the understanding the specific T and B cell response to collagen type V in Bronchioltis Obliterans Syndrome (BOS) after lung transplantation. First year award of a two year, $100,000 grant.
Northwestern University Medical Center, Chicago, Illinois ($8,518.77): Research award given to to Krishna Thavarajah, MD of the Feinberg School of Medicine to study the Relationship between Clinical Depression and its Role in the Rate of Progression in IPF.
Research Funded from 2000-2007
$8,000 to Duke University in Durham, North Carolina
Awarded to Dr. David Schwartz
$8,000 to University of Michigan in Ann Arbor, Michigan
Awarded to Dr. Galen Towes
$8,000 to University of California at Los Angeles
Awarded to Dr. Robert Strieter
$50,000 to National Jewish Health in Denver, Colorado
Awarded to Dr. Stephen K. Frankel
$25,000 to University of Michigan, Ann Arbor, Michigan
Awarded to Dr. Eric White
$35,000 to University of Pittsburgh Medical Center , Pittsburgh, Pennsylvania
Awarded to Dr. Yingze Zhang
$50,000 to Baylor College of Medicine, Houston, Texas
Awarded to Dr. Pyong Woo Park. Co-funded with the American Lung Association.
$15,000 to American College of Chest Physicians, Northbrook, Illinois
Conference on the Early and Accurate Diagnosis of IPF
$45,000 to University of Vermont, Burlington, Vermont
Awarded to Navdeep Singh, MBBS and Baylor College of Medicine, awarded to Dr. Joseph N. Walter, co-funded with the American College of Chest Physicians for Research in IPF
$50,000 to Brigham and Women's Hospital, Boston, Massachusetts.
Dr. Caroline A. Owen, co-funded with the American Thoracic Society for Research in IPF
$20,000 to Duke University
Awarded to Dr. David Schwartz to study the genetics of IPF, co-funded with the William E. Simon Foundation
$50,000 to Baylor College of Medicine, Houston, Texas
Awarded to Dr. Pyong Woo Park, co-funded with the American Lung Association. 2nd year grant
$50,000 to Brigham and Women's Hospital, Boston, Massachusetts
Dr. Caroline A. Owen, co-funded with the American Thoracic Society for Research in IPF. 2nd year grant
$45,000 Co-funded with American College of Chest Physicians
Recipients to be determined November 1, 2004
$40,000 to Massachusetts General Hospital.
Awarded to Dr. Andrew M. Tager to study the Regulation of IPF by LPA and its Receptor LPA1. September 1, 2006
$10,000 to the American College of Chest Physicians for Pulmonary Fibrosis Research
$5,000 to the Willett Foundation
Provides funding for needy patients who are undergoing Lung Transplants
$5,000 to the University of Vermont.
To help support a conference on "Stem Cells and Cellular Therapies in Lung Biology and Lung Diseases. The other sponsors are: National Institutes of Health, American Thoracic Society, the University of Vermont College of Medicine, Alpha-1 Foundation and the Vermont Lung Center
$40,500 to Brigham and Women's Hospital.
Awarded to Dr. Scott L. Schissel to study ACLP Regulation of Myofibroblast-mediated Collagen Matrix Remodeling in Pulmonary Fibrosis
$100,000 to University of Michigan.
Awarded to Dr. Galen Toews to study the possibility that the Epstein-Barr virus leads to an increased production of lung fibrocytes which cause IPF
Pending Research Awards
Rare Disease Lung Consortium ($50,000): Co-funding with the RDLC for Clinical Training in IPF Treatment
